Marmara University
Istanbul, Turkey (Türkiye)
NCT Number: NCT05175482
To evaluate impact of Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination among University Students
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Istanbul, Turkey (Türkiye)
In this randomized controlled study, it aims to evaluate impact of Health Belief Model based virtual education on Human Papilloma Virus Infection and Vaccination among University Students.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
health belief model based virtual education
Time frame: baseline and next day after the education (at first day)
The scale consists of 10 items. A higher score represents a higher knowledge level.
Time frame: baseline and next day after the education (at first day)
The scale consists of 14 items. The construction of the scale consists of perceived severity (n=4 items), perceived susceptibility (n=2 items), perceived benefit (n=3 items), perceived barriers (n=5 items). A 4-point Likert scale was used to assess each item.
Marmara University
Other
The Impact of Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination Among University Students: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05204030
Human Papilloma Virus, Infections
Fayetteville, Arkansas, United States
View Trial DetailsNCT03729518
Carcinoma, Carcinoma, Squamous Cell
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT04716127
Cervical Cancer, Female Urogenital Diseases
Montpellier, Herault, France
View Trial DetailsNCT03943875
Efficacy, Human Papilloma Virus
Galveston, Texas, United States
View Trial Details